Threats to validity of observational studies on disease-modifying antirheumatic drug therapies for rheumatoid arthritis: new aspects after the fall of the pyramid and the rise of new therapeutics

Curr Rheumatol Rep. 2003 Dec;5(6):409-12. doi: 10.1007/s11926-003-0048-y.
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / diagnosis*
  • Arthritis, Rheumatoid / drug therapy*
  • Cohort Studies
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Forecasting
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Long-Term Care
  • Male
  • Prognosis
  • Range of Motion, Articular / drug effects
  • Range of Motion, Articular / physiology
  • Recovery of Function
  • Reproducibility of Results
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Antirheumatic Agents
  • Immunosuppressive Agents